1. Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and risk of cancer.
Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and risk of cancer. A relative risk greater than 1.0 indicates an increased risk for cancer. *Yang and coauthors35 reported estimates separately for two groups totalling 205 cases of cancer: those with a leukocyte count of 5.8 × 109/L or greater, and those with a lower leukocyte count. †Total number of cancer cases was higher than the number reported among people using ACE inhibitors or angiotensin-receptor blockers. ‡Total number of cancer cases was higher than the number reported among people not using ACE inhibitors or angiotensin-receptor blockers. CI = confidence interval, NA = not available.
Chan Yoon et al. CMAJ 2011;183:E1073-E1084
©2011 by Canadian Medical Association